Skip to main content

Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.

Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P

Publication: Kidney Int (2004) • Vol 65 • Page 323PMID: 14675066View on PubMed

Purpose

The purpose of this paper was to determine if the urine protein profile, as determined by surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS), was influenced by patient (gender, blood in the urine, urine dilution), acquisition (sequential collection), storage (duration, freeze thaw cycling), or analytical factors (matrix composition, instrument settings).

Conclusion

The authors report that matrix composition and instrument settings affected peak detection and reproducibility. While 5 freeze-thaw cycles resulted in a loss of peaks, 4 cycles or less had minimal effects on urine protein profiles. Effects of storage duration were dependent upon gender and sequential collection: storage of mid-stream specimens for 3 days at 4 degrees C yielded little to no effect in terms of the number of peaks observed, while storage of first stream samples resulted in new low molecular weight peaks; and comparison among first and mid-stream specimens yielded differences in the spectral profile for females alone. The presence of blood in the urine specimen introduced new peaks corresponding to serum proteins. Fluid loading that exceeded 2L per day also impacted the spectral profile of urine specimens.

Studies (2)

Purpose

The purpose of this paper was to determine if the urine protein profile, as determined by surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS), was influenced by analytical factors (matrix composition, instrument settings).

Summary of Findings

Varying concentrations (20-100%) of matrix solutions resulted in a universal effect on observed peak number. Spot sampling protocol also influenced peak number in diluted and undiluted urine specimens.
  • Biospecimens

    FluidUrine
  • Preservation Types

    Frozen
  • Diagnoses

    Not specified
  • Platforms

    ProteinSELDI-TOF MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsAliquot size/volume
    Concentrated urine
    Diluted urine (1:16)
    Diluted urine (1:2)
    Diluted urine (1:4)
    Diluted urine (1:8)
    Undiluted urine
    SELDI-TOF MS SpecificReaction solution
    20%, 35%, 50%, or 100% CHCA
    20%, 35%, 50%, or 100% SPA